Boothbay Fund Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-39,746
| Closed | -$1.15M | – | 1651 |
|
2024
Q4 | $1.15M | Sell |
39,746
-14,633
| -27% | -$422K | 0.03% | 496 |
|
2024
Q3 | $1.29M | Hold |
54,379
| – | – | 0.03% | 556 |
|
2024
Q2 | $940K | Buy |
54,379
+31,778
| +141% | +$549K | 0.02% | 633 |
|
2024
Q1 | $505K | Buy |
+22,601
| New | +$505K | 0.01% | 858 |
|
2023
Q1 | – | Sell |
-4,066
| Closed | -$94.5K | – | 2238 |
|
2022
Q4 | $94.5K | Buy |
+4,066
| New | +$94.5K | ﹤0.01% | 1560 |
|
2022
Q3 | – | Sell |
-2,006
| Closed | -$39K | – | 2353 |
|
2022
Q2 | $39K | Buy |
+2,006
| New | +$39K | ﹤0.01% | 1833 |
|